Purpose:
To advocate for the MedTech industry with relevant stakeholders across the key areas in healthcare policy, reimbursement, regulatory, industry development and sustainability. The Committee provides oversight of Reimbursement, Industry Policy subcommittees for coordinated and aligned strategies and communications.
Objectives:
- Develop and implement an advocacy program which includes active stakeholder engagement to promote the policy positions on strategic issues identified by its subcommittees.
- Oversee implementation and content of the Digital Advocacy Platform.
MTAA Secretary: Edward Strong, Communications and Public Affairs Coordinator
MTAA Committee Lead: Matthew Versi, Public Affairs and Advocacy Manager
Member | Company |
Susan Martin (Chair and Board Director) | Johnson & Johnson Medical |
Chris Czelecky (Board Director) | Olympus |
Daniel Kildea (Chair of Industry Policy Committee) | Johnson & Johnson Medical |
Mahesh Datar (Chair of Regulatory Committee) | Medtronic |
Michael Simmonds (Chair of Reimbursement Committee) | Boston Scientific |
Beth Roberts | KLS Martin Australia |
Paul Davies | Abbott |
Mark Taffa | Horten Medical |
Liz Carnabuci | Medtronic |
Robyn Chu | Alcon |
Michael Reynolds | Biotronik |
Fraser Cleave | LifeHealthcare |
Clinton Lubcke | Baxter Healthcare |
Polo Guilbert-Wright | Edwards Lifesciences |
Julia Wenner | Terumo Blood and Cell Technologies |
Justin Keenan | Cook Medical |
Alex Best | Johnson & Johnson Medical |
James Doyle | Stryker |
Meeting dates for 2021:
- Tuesday, 2 February
- Tuesday, 30 March
- Wednesday, 2 June
- Tuesday, 10 August
- Tuesday, 5 October
- Tuesday, 16 November
